Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, Kjer-Nielsen L, Mifsud NA, Tait BD, Holdsworth R, Almeida CA, Nolan D, Macdonald WA, Archbold JK, Kellerher AD, Marriott D, Mallal S, Bharadwaj M, Rossjohn J, McCluskey J.
Chessman D, et al. Among authors: bharadwaj m.
Immunity. 2008 Jun;28(6):822-32. doi: 10.1016/j.immuni.2008.04.020.
Immunity. 2008.
PMID: 18549801
Free article.